Other genes which have been associated with breast cancer susceptibility of moderate penetrance, and their mutations are relatively common among breast cancer cases, are ATM, BARD1, RAD51C, and RAD51D, but the importance of identifying pathogenic mutations of these genes in clinical practice has not been well established [9,10,11,12,13,14]. This evidence concerns the gene RAD51D and breast carcinoma.